These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 3931905)
1. Enzymes of uracil catabolism in normal and neoplastic human tissues. Naguib FN; el Kouni MH; Cha S Cancer Res; 1985 Nov; 45(11 Pt 1):5405-12. PubMed ID: 3931905 [TBL] [Abstract][Full Text] [Related]
2. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Ho DH; Townsend L; Luna MA; Bodey GP Anticancer Res; 1986; 6(4):781-4. PubMed ID: 3752956 [TBL] [Abstract][Full Text] [Related]
3. Pyrimidine catabolism: individual characterization of the three sequential enzymes with a new assay. Traut TW; Loechel S Biochemistry; 1984 May; 23(11):2533-9. PubMed ID: 6433973 [TBL] [Abstract][Full Text] [Related]
4. A radiochemical assay for beta-ureidopropionase using radiolabeled N-carbamyl-beta-alanine obtained via hydrolysis of [2-(14)C]5, 6-dihydrouracil. Van Kuilenburg AB; Van Lenthe H; Van Gennip AH Anal Biochem; 1999 Aug; 272(2):250-3. PubMed ID: 10415095 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil. Naguib FN; Hao SN; el Kouni MH Cancer Res; 1994 Oct; 54(19):5166-70. PubMed ID: 7923135 [TBL] [Abstract][Full Text] [Related]
6. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy]. Shirasaka T; Fujii S Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of 6-azauracil on beta-alanine metabolism in rat. Tamaki N; Fujimoto S; Mizota C; Kaneko M; Kikugawa M J Nutr Sci Vitaminol (Tokyo); 1989 Oct; 35(5):451-61. PubMed ID: 2632679 [TBL] [Abstract][Full Text] [Related]
8. Behavior of activities of thymidine metabolizing enzymes in human leukemia-lymphoma cells. Shiotani T; Hashimoto Y; Tanaka T; Irino S Cancer Res; 1989 Mar; 49(5):1090-4. PubMed ID: 2917346 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts. Tatsumi K; Fukushima M; Shirasaka T; Fujii S Jpn J Cancer Res; 1987 Jul; 78(7):748-55. PubMed ID: 3114201 [TBL] [Abstract][Full Text] [Related]
10. Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes. Rosenbaum K; Jahnke K; Curti B; Hagen WR; Schnackerz KD; Vanoni MA Biochemistry; 1998 Dec; 37(50):17598-609. PubMed ID: 9860876 [TBL] [Abstract][Full Text] [Related]
11. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy. Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196 [TBL] [Abstract][Full Text] [Related]
12. Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism. Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB Pharmacogenet Genomics; 2008 Jan; 18(1):25-35. PubMed ID: 18216719 [TBL] [Abstract][Full Text] [Related]
13. Pyrimidine-degrading enzymes. Purification and properties of beta-ureidopropionase of Euglena gracilis. Wasternack C; Lippmann G; Reinbotte H Biochim Biophys Acta; 1979 Oct; 570(2):341-51. PubMed ID: 115499 [TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the metabolism of new fluorinated pyrimidine drugs in the liver by in vivo 19F magnetic resonance spectroscopic observation. Harada M; Nishitani H; Koga K; Miura I; Kimura A Jpn J Cancer Res; 1993 Feb; 84(2):197-202. PubMed ID: 8463136 [TBL] [Abstract][Full Text] [Related]
15. Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism. Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB Pharmacogenet Genomics; 2007 Nov; 17(11):973-87. PubMed ID: 18075467 [TBL] [Abstract][Full Text] [Related]
16. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase. Tuchman M; Ramnaraine ML; O'Dea RF Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028 [TBL] [Abstract][Full Text] [Related]
17. Detection of beta-ureidopropionase deficiency with HPLC-electrospray tandem mass spectrometry and confirmation of the defect at the enzyme level. Van Kuilenburg AB; Van Lenthe H; Assmann B; Göhlich-Ratmann G; Hoffmann GF; Bräutigam C; Wevers RA; Van Gennip AH J Inherit Metab Dis; 2001 Dec; 24(7):725-32. PubMed ID: 11804209 [TBL] [Abstract][Full Text] [Related]
18. Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancer. Heslin MJ; Yan J; Weiss H; Shao L; Owens J; Lucas VS; Diasio RB Cancer Chemother Pharmacol; 2003 Nov; 52(5):399-404. PubMed ID: 12904894 [TBL] [Abstract][Full Text] [Related]
19. 3-Cyano-2,6-dihydroxypyridine (CNDP), a new potent inhibitor of dihydrouracil dehydrogenase. Tatsumi K; Yamauchi T; Kiyono K; Kishi K; Yanagihara Y; Imaoka T; Kawaguchi T; Kubo M J Biochem; 1993 Dec; 114(6):912-8. PubMed ID: 8138551 [TBL] [Abstract][Full Text] [Related]
20. Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine. Ohse M; Matsuo M; Ishida A; Kuhara T J Mass Spectrom; 2002 Sep; 37(9):954-62. PubMed ID: 12271438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]